Molecular Matrix, Inc

Molecular Matrix, Inc., based in Rancho Cordova, CA, has been a pioneer in biotechnology and biomedical engineering since its inception in 2011, focusing on innovative therapeutics to enhance patient care. The company is dedicated to advancing osteobiologic technologies, particularly through its Osteo-P BGS product, a next-generation bone graft substitute that has significantly transformed orthopedic outcomes since its FDA clearance in 2017.

Driven by a mission to accelerate healing and improve recovery, Molecular Matrix emphasizes the importance of human mobility and addresses the challenges of bone loss and injuries. Their product offerings are inspired by natural physiological processes, ensuring effective and safer solutions for orthopedic spine and trauma care.

Generated from the website